Trial Profile
A retrospective, cohort study of Bortezomib in patients with multiple myeloma to evaluate patterns of bortezomib-associated neuropathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 Nov 2015 New trial record